| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/28/2008 | EP1924557A2 Carbazole derivatives |
| 05/28/2008 | EP1924327A2 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer |
| 05/28/2008 | EP1924254A2 Use of tellurium compounds for protection from ultra-violet radiation |
| 05/28/2008 | EP1756118B1 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 05/28/2008 | EP1723415A4 Pdes as modifiers of the igfr pathway and methods of use |
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | EP1692123B1 Phenyl-furan compounds as vitamin d receptor modulators |
| 05/28/2008 | EP1691805B1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1641820B1 Rasgap derived peptide for selectively killing cancer cells |
| 05/28/2008 | EP1605946B1 Thiazoles useful as inhibitors of protein kinases |
| 05/28/2008 | EP1592449B1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 05/28/2008 | EP1563307B1 Tumour marker proteins and uses thereof |
| 05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1404864A4 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
| 05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
| 05/28/2008 | EP1377251B1 A cell therapy method for the treatment of tumors |
| 05/28/2008 | EP1370684B1 Polynucleotides related to colon cancer |
| 05/28/2008 | EP1343476B1 Preparation of large liposomes by infusion into peg |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1263431B1 Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1157105B1 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 05/28/2008 | CN101189266A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 05/28/2008 | CN101189258A A peptide ligand to impair cancer cell migration |
| 05/28/2008 | CN101189249A Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189240A Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 05/28/2008 | CN101189239A Protein kinase inhibitors |
| 05/28/2008 | CN101189024A Stabilised IL-21 compositions |
| 05/28/2008 | CN101189023A 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 05/28/2008 | CN101189014A Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 05/28/2008 | CN101189003A Pharmaceutical formulations of HDAC inhibitors |
| 05/28/2008 | CN101186936A Method for producing dry bacterium powder containing gamma-linolenic acid |
| 05/28/2008 | CN101186921A Novel gene Xsynuclein for xenopus laevis GRK family |
| 05/28/2008 | CN101186650A Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 05/28/2008 | CN101186613A Cytotoxic agents comprising new maytansinoids |
| 05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186609A Methods of preparing and purifying 9-nitro-20-camptothecin and 9-nitro-20-camptothecin and its compositions |
| 05/28/2008 | CN101186606A Ampelopsin derivative, synthesizing method thereof and application of the same in preparing antineoplastic medicine |
| 05/28/2008 | CN101186598A 1-oxy-acetyl inula Britannica lactone derivative, preparation method thereof and application of the same in preparing cancer-curing medicine |
| 05/28/2008 | CN101186596A Novel compound tatarine D and separating identification method thereof |
| 05/28/2008 | CN101186594A (Z)-2,4-dimethoxy-6-styryl-5-(Schiff's base or benzoylhydrazone)benzene compounds and preparation method thereof |
| 05/28/2008 | CN101186563A 3,5-dimethoxyl or 3,5-dihydroxy diphenylethene compounds and preparation method thereof |
| 05/28/2008 | CN101185763A Use of duplicating type recombinant adenovirus |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185754A Novel MHC II associated peptides |
| 05/28/2008 | CN101185693A New use of scyphiphora hydrophyllacea and its extract in preparing anti-liver-cancer medicine |
| 05/28/2008 | CN101185678A Liquid for eliminating tumor |
| 05/28/2008 | CN101185671A Anti-tumor medicine extracted from Juglans regia and preparation method thereof |
| 05/28/2008 | CN101185661A Technique for preparing liverwort extract and application of it in preparing medicine for treating liver cancer and hepatitis B |
| 05/28/2008 | CN101185654A Gemcitabine hydrochloride or gemcitabine composition |
| 05/28/2008 | CN101185652A Remedies for lung cancer |
| 05/28/2008 | CN101185649A Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 05/28/2008 | CN101185643A Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 05/28/2008 | CN101185636A Oridonin injection and power injection containing sulfobutyl ether beta-cyclodextrin and preparation method thereof |
| 05/28/2008 | CN101185634A Topotecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185633A Neratinib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185632A Lonafarnib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185631A Vandetanib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185630A Temozolomide sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185629A Decitabine sustained-release preparation for treating solid tumor |
| 05/28/2008 | CN101185628A Irinotecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185627A Nilotinib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185626A Marimastat sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185625A Rubitecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185454A Nutrition bread |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/28/2008 | CN100390291C Conditionally replicating viral vectors and their use |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390282C Immunocytokines with modulated selectivity |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390167C Total synthesis of myriaporones |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390149C Indazole derivatives |
| 05/28/2008 | CN100390148C Method for the treatment of malignant tumours |
| 05/28/2008 | CN100389829C Identification method of compound for inhibiting tumour injury and medicinal compositions containing said compound |
| 05/28/2008 | CN100389825C Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 05/28/2008 | CN100389824C 联合疫苗组合物 Combined vaccine composition |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389798C Litchi peel extract, its preparation method and purposes |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/28/2008 | CN100389772C Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 05/28/2008 | CN100389748C Chemotherapeutic emulsion for treating rectum cancer |
| 05/28/2008 | CN100389662C Method for preparing soymilk tablets contg. micron Grifola frondosa powder and glossy ganoderma spore powder for anti-tumor mutation |
| 05/27/2008 | US7378532 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378503 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378443 Fatty acid analogues for the treatment of cancer |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |